SAN ANTONIO, Dec. 6, 2017 /CNW/ -- Alternate Health Corp. ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international, vertically-integrated medical cannabis company, today announced that the Company's CEO, Dr. Michael Murphy, will be webcasting live and answering questions from investors on Dec. 7, 2017.
This will be a live, interactive online event where investors are invited to ask Dr. Murphy questions in real-time – both in the presentation hall and the association's "virtual trade booth." If attendees are unable to join the event live on the day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register and run the online system check to save time and receive event updates.
Receipt of Medicare license approval for Alternate Health Labs
Installation of CanaPass software platform is progressing well and should be completed by year-end in National Access Cannabis' 11 Canadian clinics serving 12,000 clients.
CanaPass Florida-specific adaption FlorPass has launched in Florida clinics making inroads into other states with additional adaptations.
Negotiated the acquisition of a Blockchain-Enabled Mobile Payment software application completed in November, adding mobile payment solutions and point of sale capabilities.
Alternate Health Lab conversion to a full clinical lab is expected to continue generating long-term stable revenues.
About Alternate Health Corp. Alternate Health Corp. (CSE: AHG, OTCQB: AHGIF) Alternate Health has established multiple arms-length operations within the medical cannabis industry, each of which drives consumers, data and strategic opportunities to the company's other verticals. This sophisticated cross-integration of the company's enterprises has positioned Alternate Health as one of the only cannabis companies that delivers consistent revenue and intellectual property without growing, manufacturing or distributing the cannabis plant. Through its software solutions, data analytics, and patented delivery systems, Alternate Health's goal is to be the global authority on scientific and clinical support for cannabis in regulated markets.
Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders.
Alternate Health resides in the cannabis sector along with companies like GW Pharmaceuticals, AXIM Biotechnologies Inc., Canopy Growth Corporation, and Aphria Inc. Alternate Health is differentiated from other cannabis companies by its focus on ancillary services for patients, healthcare professionals and regulatory providers rather than selling a commodity. For more information about Alternate Health Corp., visit www.alternatehealth.ca
About VirtualInvestorConferences.com Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward looking statements.
SOURCE Alternate Health Corp.
For further information: Investor Relations Contact: Nancy Goertzen, CPIR, 1.604.512.7122, [email protected]; VirtualInvestorConferences.com Contact: John Viglotti, VP, Investor Relations Products and Services, Cision / PR Newswire / MultiVu, Phone 201 360 6767 | Mobile 212 729 8350, [email protected], http://www.alternatehealth.ca